What is Zelnorm?

Zelnorm (tegaserod maleate) is a medicine or drug used for the short-term treatment of primarily women who have irritable bowel syndrome with constipation (IBS-C) as their main bowel problem.

IBS is a disorder that interferes with the normal functions of the large intestine (colon). Symptoms may include cramps, abdominal pain, bloating, constipation, and/or diarrhea. The cause of IBS is unknown. Zelnorm works by increasing the movement of stools through the bowels.  Zelnorm was approved on July 24, 2002, for short term treatment of women with irritable bowel syndrome (IBS) whose primary bowel symptom is constipation.   On August 21, 2004, FDA approved Zelnorm or another use, the indication of chronic idiopathic constipation. The FDA encourages those people who are taking Zelnorm to contact their doctor and discuss appropriate alternative treatments.  Patients who are taking Zelnorm should seek emergency medical care right away if they experience severe chest pain, shortness of breath, dizziness, sudden onset of weakness or difficulty walking or talking or other symptoms of a heart attack or stroke.  Contact a lawyer at our firm if you have taken Zelnorm and have suffered any serious side effects. When you choose us to handle your case, our entire team becomes fully committed to your cause. We’ll find answers, hold negligent companies responsible and get you the compensation you rightly deserve.

If you or a family member have suffered a heart attack or a stroke - call our Law Firm we can help.  CALL TOLL FREE 1-800-862-1260.

Zelnorm is a trademark of Novartis Corporation.

The Carabin & Shaw Law Firm, its' lawyers and this website is in no way affiliated with Novartis Corporation. The use of this mark is solely for informational and product identification purposes.